HER2 + BREAST CANCER

Clinical trials for HER2 + BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HER2 + BREAST CANCER trials appear

Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1

New study tests targeted pill combo for advanced breast cancer in Real-World settings

Disease control Not yet recruiting

This study will follow 500 people with advanced HER2-positive breast cancer who are receiving pyrotinib (a daily pill) as their first or second treatment. Researchers want to see how well the drug works in real life and whether switching to another targeted therapy (Trastuzumab R…

Matched conditions: HER2 + BREAST CANCER

Phase: PHASE4 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Jun 23, 2026 11:58 UTC

HER2 + BREAST CANCER

Get alerted when new HER2 + BREAST CANCER trials appear

New study tests targeted pill combo for advanced breast cancer in Real-World settings